Hyperglycemia and hyperinsulinemia at diagnosis of diabetes and their association with subsequent cardiovascular disease in the United Kingdom Prospective Diabetes Study (UKPDS 47)

American Heart Journal

Volumn 138, Issue 5 I, 1999, Pages

  Adler, A I ^a   Neil, H A W ^a   Manley, S E ^a   Holman, R R ^a   Turner, R C ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ANGINA PECTORIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONFERENCE PAPER; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; ISCHEMIC HEART DISEASE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; UNITED KINGDOM;

EID: 0032693603     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(99)70035-9     Document Type: Conference Paper

References (54)

1. Adler A, Matthews D, Holman R, et al. Type 2 diabetes and death: causes, estimated life expectancy, and mortality rates; the United Kingdom Diabetes Study [abstract]. Diabetes 1998;47:A71.
2. Kannel W, McGee D. Diabetes and cardiovascular disease: the Framingham study. JAMA 1979;241:2035-8.
3. Stamler J, Vaccaro O, Neaton JD, et al. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434-44.
4. Folsom AR, Szklo M, Stevens J, et al. A prospective study of coronary heart disease in relation to fasting insulin, glucose, and diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care 1997;20:935-42.
5. Lowe LP, Liu K, Greeland P, et al. Diabetes, asymptomatic hyperglycemia, and 22-year mortality in black and white men: the Chicago Heart Association Detection Project in Industry City. Diabetes Care 1997;20:163-9.
6. Welborn T, Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 1979;2:154-60.
7. Despres J, Lamarche B, Mauriege P, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996;334:952-7.
8. UKPDS Group. UK Prospective Diabetes Study VIII: study design, progress and performance. Diabetologia 1991;34:877-90.
9. American Diabetes Association. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1998;21(suppl 1):S5-19.
10. UKPDS Group. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 32). Lancet 1998;352:837-53.
11. UKPDS Study Group. Ethnicity and cardiovascular disease: the incidence of myocardial infarction in whites, South Asians, and Afro-Caribbean patients with type 2 diabetes (UKPDS 32). Diabetes Care 1998;12:1271-7.
12. UKPDS Group. UK Prospective Diabetes Study XI: biochemical risk factors in type 2 diabetic patients at diagnosis compared with age-matched normal subjects. Diabet Med 1994;11:534-44.
13. Tunstall-Pedoe H. Coronary heart disease. BMJ 1991;303:701-4.
14. Gu K, Cowie C, Harris M. Diabetic adults experienced smaller declines in heart disease mortality than nondiabetic adults in the US population, 1971-93 [abstract]. Diabetes 1998;47:A11.
15. Turner R, Millns H, Neil H, et al. UK Prospective Diabetes Study (UKPDS) 23: risk factors for coronary artery disease in non-insulin dependent diabetes. BMJ 1997;316:823-8.
16. Moss S, Klein R, Klein B, et al. The association of glycemia and cause-specific mortality in a diabetic population. Arch Intern Med 1994;154:2473-9.
17. Yano K, Kagan A, McGee D, et al. Glucose intolerance and 9-year mortality in Japanese men in Hawaii. Am J Med 1982;72:71-80.
18. Standl E, Balletshofer B, Dahl B, et al. Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: the Munich General Practitioner Project. Diabetologia 1996;39:1540-5.
19. Hanefeld M, Fischer S, Julius U, et al. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia 1996;39:1577-83.
20. Lehto S, Ronnemaa T, Haffner S, et al. Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM. Diabetes 1997;48:1354-9.
21. Stegmayr B, Asplund K. Diabetes as a risk factor for stroke: a population perspective. Diabetologia 1995;38:1061-8.
22. Manson JE, Colditz GA, Stampfer MJ, et al. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med 1991;151:1141-7.
23. Manolio T, Kronmal R, Burke G, et al. Short-term predictors of incident stroke in older adults. Stroke 1996;27:1479-86.
24. Lehto S, Ronnemaa T, Pyorola K, et al. Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes. Stroke 1996;27:63-8.
25. Vlassara H. Recent progress in advanced glycation end products and diabetic complications. Diabetes 1997;46:S19-25.
26. Brownlee M. Glycation and diabetic complications. Diabetes 1994;43:836-41.
27. Schmidt A, Hori O, Cao R, et al. RAGE: a novel cellular receptor for advanced glycation end products. Diabetes 1996;45(suppl 3):S77-80.
28. Colwell J, Lopes-Virella M, Halushka P. Pathogenesis of atherosclerosis in diabetes mellitus. Diabetes Care 1981;4:121-33.
29. Koya D, King G. Protein kinase C activation and the development of diabetic complications. Diabetes 1998;47:859-66.
30. Schror K. Blood vessel wall interactions in diabetes. Diabetes 1997;46(suppl 2):S115-8.
31. Ceriello A. Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects. Diabetologia 1993;36:1119-25.
32. Durrington P. Is insulin atherogenic? Diabet Med 1992;9:597-600.
33. Schneider D, Absher P, Neimane D, et al. Fibrinolysis and atherogenesis in the JCR:LA-cp rate in relation to insulin and triglyceride concentrations in blood. Diabetologia 1998;41:141-7.
34. Schneider D, Nordt T, Sobel B. Attenuated fibrinolysis and accelerated atherogenesis in type II diabetic patients. Diabetes 1993;42:1-7.
35. Haffner S, Meittinen H. Insulin resistance implications for type II diabetes mellitus and coronary heart disease. Am J Med 1997;103:152-62.
36. Reaven G. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
37. Reaven G, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities: the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996;334:374-81.
38. Suzuki M, Ikebuchi M, Shnozaki K, et al. Mechanism and clinical implication of insulin resistance syndrome. Diabetes 1996;45(suppl 3):S52-4.
39. Folsom A, Eckfeldt J, Weitzman S, et al, for the Atherosclerosis Risk in Communities (ARIC) study investigators. Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity. Stroke 1994;25:66-73.
40. Pinkney J, Stehouwer C, Coppack S, et al. Endothelial dysfunction: cause of the insulin resistance syndrome. Diabetes 1997;46:S9-13.
41. Fontbonne A, Charles M, Thibult N, et al. Hyperinsulinemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up. Diabetologia 1991;34:356-61.
42. Perry IJ, Wannamethee S, Whincup P, et al. Serum insulin and incident coronary heart disease in middle-aged British men. Am J Epidemiol 1996;144:224-34.
43. Ferrara A, Barrett-Connor E, Edelstein S. Hyperinsulinemia does not increase the risk of fatal cardiovascular disease in elderly men or women with diabetes: the Rancho Bernardo Study, 1984-1991. Am J Epidemiol 1994;140:857-69.
44. Pyorala M, Miettinen H, Laakso M, et al. Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Circulation 1998;98:398-404.
45. Pyorala M, Miettinen H, Laakso M, et al. Hyperinsulinemia and the risk of stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Stroke 1998;29:1860-6.
46. Welin L, Eriksson J, Larsson B, et al. Hyperinsulinemia is not a major coronary risk factor in elderly men: the study of men born in 1913. Diabetologia 1992;35:766-70.
47. Rantala A, Paivansalo M, Kauma H, et al. Hyperinsulinemia and carotid atherosclerosis in hypertensive and control subjects. Diabetes Care 1998;21:1188-93.
48. Hanefeld M, Schmechel H, Schwanebeck U, et al. Predictors of coronary heart disease and death in NIDDM: the Diabetes Intervention Study experience. Diabetologia 1997;40:S123-4.
49. Yudkin J, Nagi D, Denver AE, et al. The relationship of concentrations of insulin and proinsulin-like molecules with coronary heart disease prevalence and incidence. Diabetes Care 1997;20:1093-100.
50. Wingard D, Barrett-Connor E, Ferrara A. Is insulin really a heart disease risk factor? Diabetes Care 1995;18:1299-304.
51. Jarrett R. Why is insulin not a risk factor for coronary heart disease? Diabetologia 1994;37:945-7.
52. Hennekens C, Buring J. Epidemiology in medicine. Boston: Little, Brown; 1987. p. 289.
53. Kuusisto J, Mykkanen L, Pyorala K, et al. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 1994;43:960-7.
54. Gruber W, King H. The WHO National Diabetes Programme Initiative. Diabetes Res Clin Pract 1996;34:S1-6.